Lilly E-Mail Discussed Off-Label Drug Use - New York Times

Lilly E-Mail Discussed Off-Label Drug Use - New York Times: "“The fact we are now talking to child psychs and peds and others about Strattera means that we must seize the opportunity to expand our work with Zyprexa in this same child-adolescent population,” Dr. Lechleiter wrote in the message. He also encouraged Lilly to get data on the use of Zyprexa in treating “disruptive kids” in order to increase the drug’s sales."

Monsters.